Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Xbiotech Inc (XBIT)

Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xbiotech Inc 5217 WINNEBAGO LANE AUSTIN TX 78744 USA

www.xbiotech.com Employees: 92 P: 512-386-2900 F: 512-386-5505

Sector:

Medical

Description:

XBiotech Inc. is a biopharmaceutical company. The Company is engaged in discovering and developing True Human(TM) monoclonal antibodies for treating diseases. XBiotech Inc. is based in AUSTIN, United States.

Key Statistics

Overview:

Market Capitalization, $K 78,354
Enterprise Value, $K -84,076
Shares Outstanding, K 30,488
Float, K 21,098
% Float 69.20%
Short Interest, K 100
Short Float 0.33%
Days to Cover 2.62
Short Volume Ratio 0.49
% of Insider Shareholders 30.80%
% of Institutional Shareholders 55.70%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -38,530 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,010 K
EBIT, $ -34,690 K
EBITDA, $ -32,940 K

Growth:

1-Year Return -33.77%
3-Year Return -43.02%
5-Year Return -86.49%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -85.29%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.20 on 11/12/25
Next Earnings Date 03/17/26
Earnings Per Share ttm -0.96
EPS Growth vs. Prev Qtr -233.33%
EPS Growth vs. Prev Year -25.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

XBIT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -16.73%
Return-on-Assets % -15.93%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.47
Book Value/Share 5.48
Interest Coverage -46.60
60-Month Beta 0.81
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar